Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 04, 2017
Mylan and Aspen announced the U.S. launch of Myleran Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of Busulfex Injection.
read more
Mylan Chairman Robert J. Coury and Chief Executive Officer Heather Bresch provided additional detail regarding the company's efforts to meet public health needs amid the evolving COVID-19 pandemic.
read more
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Mylan has restarted production of hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility.
read more
Tuesday, December 01, 2020
Mustang Bio and Minaris have signed an agreement to enable technology transfer and GMP clinical manufacturing of Mustang’s MB-107 lentiviral gene therapy program for the treatment of XSCID in Europe.
read more
Headlands Research announced its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine trial.
read more
Wednesday, April 10, 2019
Moleculin Biotech announced it has successfully expanded the clinical supply of Annamycin for its on-going clinical trials via BSP Pharmaceuticals S.p.A. in Latina, Italy.
read more
Wednesday, November 01, 2017
Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and co-commercialize an mRNA therapeutic encoding for Relaxin.
read more
Moderna has announced the Company has shipped the 100-millionth dose of its COVID-19 vaccine to the U.S. Government.
read more
Thursday, August 03, 2017
Moderna announced Juan Andres has joined the company as Senior Vice President of Late Stage Technical Development and Manufacturing (beyond human proof of concept).
read more
Wednesday, March 14, 2018
Minakem has initiated the extension of its manufacturing capacity at its Dunkirk site in France.
read more
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
read more
Tuesday, October 11, 2022
Mikart, LLC to collaborate with Nano PharmaSolutions, who has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients (API).
read more
Thursday, October 20, 2022
Mikart entered into a collaboration agreement with Fluid Pharma Ltd, a technology licensing company, to advance the application of Fluid Pharma's proprietary MicroCoat™ technology in new therapies for pediatric, geriatric, and oral liquid modified ...
read more
An expert scientist in pharmaceutical formulation
development at Metrics Contract Services has been awarded a patent for intellectual property about
controlled release technology.
The U.S. Patent and Trademark Office awarded Dr. Thomas B. “Brad” ...
read more